And more drugs Flashcards
Hyperlipidemia Anti-Arrhythmias Only a couple hyperlipidemia..
MOA of statins
inhibits rate-limiting step of cholesterol synthesis, which:
- upregulates LDL receptors in liver
- reduces lipoprotein secretion in liver
Statins reduce…
LDL (50%)
TG (~37%)
(and increase HDL ~15%
Statins are predominately excreted through
feces
-mycin antibiotics, azoles, SSRI’s, CCB’s and grapefruit juice will have drug interactions with these statins:
Atorvastatin (lipitor) and Lovastatin
**via CYP3A4
Cyclosporine and grapefruit juice are contraindicated with statins because they inhibit:
p-glycoprotein mediated intestinal absorption
HMG CoA Reductase Inhibitors adverse effects: (7)
mild GI distress increased liver enzymes sleep disturbance, memory loss teratogenic myalgia without CPK rise myositis with CPK rise rhabdomyolysis with CPK rise
Statin which will have no effect on TG
lovastatins
How do bile acid sequestrants interrupt recycling of cholesterol?
bile negatively charged bile acids in the gut
Group of antilipemic drugs that are non-systemic
bile acid sequestrants
Group of antilipemic drugs that are safe for use in patients with liver disease
bile acid sequestrants
What side effects may limit use of bile acid sequestrants?
GI bloating
constipation
possible increase in TG
Bile acid sequestrants prevent the absorption of what drugs?
digoxin
beta blockers
thyroxine
coumadin
(these should be taken an hour before or 3-4 hours after BAS)
MOA of ezetimibe (zetia):
inhibits absorption of cholesterol in small intestine by 50%, which reduces delivery of cholesterol to liver
this results in upregulation of LDL receptors and increased clearance of LFL from plasma
ezetimibe (zetia) localizes to:
brush border of small intestinal epithelium
Excretion of ezetimibe (zetia):
biliary (78%) and renal
Effect of ezetimibe (zetia) on LDL, HDL, TG:
lowers LDL by ~18%
increased HDL by ~5%
lowers TG by ~11%
Drug interactions associated with ezetimibe (zetia):
- bile acid sequestrants (decrease absorption of ezetimibe by up to 80%)
- cyclosporine (3-4 fold increase in ezetimibe levels)
- fibrates (when combined, may increase biliary cholesterol excretion and increase risk of gallstones)
Most significant side effect associated with ezetimibe (zetia):
increased liver enzymes when co-administered with a statin
MOA of fibric acid derivatives
gemfibrozil and fenofibrate
serves as ligand for ligand-activated PPAR-alpha nuclear receptor, which then causes:
- supresses transcription of ApoCIII (which increases LPL)
- increased ApoA1 synthesis
- increases PL transfer protein activity
- increased FA oxidation (reduces TG synthesis)
- increased biliary cholesterol excretion via increased cholesterol 12a hydroxylase
Effects of fibric acid derivatives on: VLDL TG HDL LDL
VLDL: reduced
TG: reduced by up to 50%
HDL: increased (~15%)
LDL: unchanged/-/+
Side effects of fibric acid derivatives:
GERD, diarrhead increased liver enzymes gallstones teratogenic/embryocidal in animals pregnancy category C
Side effect specific to fenofibrate (tricor):
reversible increase in creatinine
Gemfibrozil reduces metabolism of what drugs?
statins
Gemfibrozil is a good drug choice for patients with…
unlike fenofibrate
renal disease (extensively metabolized by liver)
MOA of niacin: (5)
- inhibits mobilization of FFA from adipocytes
- reduced hepatic TG synthesis
- reduces ApoB synthesis and secretion (VLDL)
- Enhanced ATP cassette-mediated transfer of cholesterol from macrophage to HDL
- Enhances LPL (promotes conversion of VLDL to LDL)
Niacin's effects on: HDL LDL TG Lp(a)
HDL: increased (via increased plasma ApoA1)
LDL: reduced
TG: reduced
Lp(a): reduced *unique feature
Side effects of niacin:
- flushing
- increased liver enzymes, hepatitis, failure
- GI irritation and activation of peptic ulcer disease
- hyperuricemia/gout
- retinal detachment
- cystoid macular edema
- myositis
- skin dryness, etc
- insulin resistance, hyperglycemia
*SMUGGLED
(skin flushed, myositis, uric acid, GI, glu, liver, eyes, dry skin)
Effects of N3FA:
low TG antiplatelet antiarrhythmic reduced BP reduced CAD*
MOA of N3FA:
reduced hepatic TG synthesis by reducing SREBP
increased FA ox via PPAR-alpha activation
Effects of N3FA on:
HDL
LDL
TG
HDL: none
LDL: none
TG: lowers
N3FA is a formulation of ___ and ___
EPA
DHA
Class I antiarrhythmics
Examples?
Na channel blocker
lidocaine, procaine
Class II antiarrhythmics
Examples?
beta blocker
propranolol, metoprolol
Class III antiarrhythmics
Examples?
K channel blocker
amiodarone, sotalol, ibutilide
Class IV antiarrhythmics
Examples?
Ca channel blocker
verapamil, diltiazem
Phase IV depol of the SA node is slowed by
vagal activity (ACh) digoxin
Phase IV depol of the SA node is accelerated by
sympathetic activity class II drugs